Lisa Marie Evangelista, CScD, CCC-SLP, BCS-S

Associate Professor and Director of Speech Pathology

To see if Lisa Marie Evangelista is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).




Head and Neck Cancer


Swallowing Disorders



Locations and Contact

Glassrock Building

Otolaryngology Speech Audio Clinic
2521 Stockton Blvd.
Sacramento, CA 95817

Get Directions

Additional Numbers

Clinic Fax


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Clinical Interests

Dr. Lisa Evangelista is the Director of Speech Pathology at the UC Davis Medical Center, Department of Otolaryngology-Head and Neck Surgery. She earned a Doctor of Clinical Science degree from the University of Pittsburgh and is actively involved in clinical practice, academic research and educational training. She is a board-certified specialist in swallowing and swallowing disorders and serves on the American Speech-Language and Hearing Association's Head and Neck Cancer Committee and on the Board of Directors for the American Board of Swallowing and Swallowing Disorders. She provides comprehensive diagnostics and contemporary management of swallowing dysfunction following surgical interventions and radiation therapy for head and neck cancers.

Research/Academic Interests

Dr. Evangelista's research focuses on improving functional clinical outcomes following surgical and medical treatments for head and neck cancers. Her academic interests include swallowing physiology following radiation therapy, alaryngeal voice rehabilitation after total laryngectomy surgery, and quality of life outcomes following surgical and medical interventions in head and neck oncology. In addition to lecturing nationally and internationally on diagnostics and therapeutics in swallowing rehabilitation, she has authored peer-reviewed articles and book chapters on dysphagia in head and neck cancers.


Head and Neck Surgery

Center/Program Affiliation

Center for Voice and Swallowing

Undergraduate School

B.A., California State University, Fresno, Fresno CA 2007

Other School

M.A., Speech Pathology, California State University, Fresno, Fresno CA 2009

Other School

C.Sc.D., Doctor of Clinical Science, University of Pittsburgh, Pittsburgh PA 2014


Speech-Language Pathology, University of Pittsburgh Medical Center, Pittsburgh PA 2012-2014

American Board of Swallowing and Swallowing Disorders, Executive Board Member, 2021, 2022, 2023

American Speech-Language & Hearing Association, Head & Neck Committee, 2020, 2021

Jonas Salk Fellowship Award, 2013

Evangelista L, Andrews T, Nativ-Zeltzer N, Nachalon Y, Kuhn M, Belafsky P. Association of Functional Outcomes in Tracheoesophageal Voicing With Intratracheal Pressures and Esophagram Findings. JAMA Otolaryngol Head Neck Surg. 2021 Dec 1;147(12):1065-1070. doi:10.1001/jamaoto.2021.2409. PMID:34529045.

Evangelista LM, Andrews T, Bayoumi A, Kuhn MA, Nativ-Zeltzer N, Belafsky PC. Endoscopic visualization for tracheoesophageal puncture tract sizing. Acta Otolaryngol. 2021 Jun;141(6):635-639. doi:10.1080/00016489.2021.1907444. Epub 2021 Apr 7. PMID 33825666.

Olinde L, Evangelista L, Bewley AF. Functional laryngectomy for the dysfunctional larynx: indications and outcomes in setting of prior chemoradiotherapy. Curr Opin Otolaryngol Head Neck Surg. 2021 Dec 1;29(6):473-478. doi:10.1097/MOO.0000000000000757. PMID:34535008.

Nativ-Zeltzer N, Nachalon Y, Kaufman MW, Seeni IC, Bastea S, Aulakh SS, Makkiyah S, Wilson MD, Evangelista L, Kuhn MA, Sahin M, Belafsky PC. Predictors of Aspiration Pneumonia and Mortality in Patients with Dysphagia. Laryngoscope. 2021 Jul 27. doi:10.1002/lary.29770. Epub ahead of print. PMID:34313344.

Nachalon Y, Nativ-Zeltzer N, Evangelista LM, Dhar SI, Lin SJ, Shen SC, Belafsky PC. Cervical Fibrosis as a Predictor of Dysphagia. Laryngoscope. 2021 Mar;131(3):548-552. doi:10.1002/lary.28880. Epub 2020 Jul 6. PMID:32628787.

Nativ-Zeltzer N, Kuhn MA, Evangelista L, Anderson JD, Nolta JA, Farwell DG, Canestrari E, Jankowski RJ, Belafsky PC. Autologous Muscle-Derived Cell Therapy for Swallowing Impairment in Patients Following Treatment for Head and Neck Cancer. Laryngoscope. 2021 May 14. doi:10.1002/lary.29606. Epub ahead of print. PMID:33988246.

Cates DJ, Evangelista LM, Belafsky PC. Effect of Pretreatment Dysphagia on Postchemoradiation Swallowing Function in Head and Neck Cancer. Otolaryngol Head Neck Surg. 2021 May 4:1945998211009853. doi:10.1177/01945998211009853. Epub ahead of print. PMID:33940987.

Evangelista LM, Bayoumi A, Dyer BA, Shukla RP, Rao SD, Belafsky PC. The relationship between posterior pharyngeal wall thickness and swallowing function after radiation therapy. Acta Otolaryngol. 2020 Aug;140(8):693-696. doi:10.1080/00016489.2020.1752933. Epub 2020 Apr 27. PMID:32340517.

Evangelista LM. Dysphagia in Head and Neck Cancer. Early Detection and Treatment of Head and Neck Cancers, Springer. 2021;4:87-105.

Evangelista LM, Farwell DG. Swallowing Therapy in Head and Neck Cancers & Late Effects of Therapy in Head and Neck Cancers. Bailey’s Head & Neck Surgery Otolaryngology. 2021.